Cargando…
Modulation of Phospho-CREB by Systemically Administered Recombinant BDNF in the Hippocampus of the R6/2 Mouse Model of Huntington's Disease
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease due to an expansion of a trinucleotide repeats in IT15 gene encoding for the protein huntingtin. Motor dysfunction, cognitive decline, and psychiatric disorder are typical clinical signs of HD. In HD, mutated huntingti...
Autores principales: | Paldino, Emanuela, Giampà, Carmela, Montagna, Elena, Angeloni, Cecilia, Fusco, Francesca R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381568/ https://www.ncbi.nlm.nih.gov/pubmed/30881980 http://dx.doi.org/10.1155/2019/8363274 |
Ejemplares similares
-
Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease
por: Giampà, Carmela, et al.
Publicado: (2013) -
PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington’s Disease
por: Cardinale, Antonella, et al.
Publicado: (2015) -
Correction: Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington's Disease
por: Giampà, Carmela, et al.
Publicado: (2016) -
Selective Sparing of Striatal Interneurons after Poly (ADP-Ribose) Polymerase 1 Inhibition in the R6/2 Mouse Model of Huntington’s Disease
por: Paldino, Emanuela, et al.
Publicado: (2017) -
Neuroprotective Effects of Doxycycline in the R6/2 Mouse Model of Huntington’s Disease
por: Paldino, Emanuela, et al.
Publicado: (2019)